LIORESAL

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug LIORESAL contains one active pharmaceutical ingredient (API):

1 Baclofen UNII H789N3FKE8 - BACLOFEN

Baclofen depresses monosynaptic and polysynaptic reflex transmission, probably by stimulating the GABAB-receptors. This stimulation in turn inhibits the release of the excitatory amino acids glutamate and aspartate. Neuromuscular transmission is unaffected by baclofen. Baclofen also exerts an antinociceptive effect. Read about Baclofen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIORESAL Solution for intrathecal injection / infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03BX01	Baclofen	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents
Discover more medicines within M03BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2729P, 2730Q, 5617P, 6284R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526508601113419
Country: CA	Health Products and Food Branch	Identifier(s): 02131048, 02131056, 02131064
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02181224, 02181230, 02181247, 02499920, 02499937, 02499943, 03012067, 03012073, 03463700, 03463717, 03686831, 03686877, 04959194, 04959219, 08874833
Country: EE	Ravimiamet	Identifier(s): 1600782, 1623710, 1651508, 1665705, 1668113, 1753815, 1754478, 1769700, 1791222, 1803057
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 52180, 52181, 62346, 62347, 62348
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 448670, 448688
Country: FR	Base de données publique des médicaments	Identifier(s): 60304050, 62311182, 65317023, 69375846
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143008, 20024, 241200, 36264, 36268, 36271
Country: HK	Department of Health Drug Office	Identifier(s): 00226, 51460
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-455944140, HR-H-786110495
Country: IE	Health Products Regulatory Authority	Identifier(s): 39535, 59765
Country: IT	Agenzia del Farmaco	Identifier(s): 022999027
Country: JP	医薬品医療機器総合機構	Identifier(s): 1249006F1054, 1249006F2042
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 16756, 2607
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13522, 13523
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100160730, 100160746, 100224370, 100262984, 100293737, 100390765, 100423789, 100423795, 100456060, 100460776, 100461375, 100464044
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W10193001, W10193002, W10194001
Country: SG	Health Sciences Authority	Identifier(s): 05330P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283081
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504010077
Country: US	FDA, National Drug Code	Identifier(s): 70257-560, 70257-561, 70257-562, 70257-563
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/2.10/227, E/2.10/228